MIR508 Gene

HGNC Family Non-coding RNAs
Name microRNA 508
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies demonstrate that MIR508 isoforms, encompassing both miR‑508‐5p and miR‑508‑3p, serve as powerful tumor‐suppressive regulators in a variety of human cancers. For example, in renal cell carcinoma the downregulation of miR‑508‑3p has been linked to enhanced proliferation and migration, underscoring its role as a tumor suppressor."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In gastric cancer, miR‑508‑5p reverses multidrug resistance by directly targeting key mediators such as ABCB1 and ZNRD1 and by suppressing oncogenic drivers like SKP2, thereby sensitizing tumors to chemotherapy."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "2", "end_ref": "4"}]}, {"type": "t", "text": " In esophageal squamous cell carcinoma, direct suppression of multiple phosphatases via miR‑508 contributes to constitutive PI3K/Akt signaling and an aggressive phenotype."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Moreover, in glioma and hepatocellular carcinoma, restoration of miR‑508‑5p expression reduces cell proliferation and invasion through targeting molecules such as GPNMB and MESDC1."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " In colorectal cancer, aberrant miR‑508 expression is associated with a mesenchymal, stem‐like subtype that features enhanced epithelial–mesenchymal transition and poor patient outcome"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": ", while in ovarian cancer, targeting of effectors such as MAPK1, CCNA2, and MMP7 by miR‑508 diminishes proliferation and invasion."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "11"}]}, {"type": "t", "text": " In addition, circulating miR‑508 variants have been identified as promising biomarkers, with diagnostic and prognostic value in clear cell renal cell carcinoma and ovarian cancer."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": " Restoration of miR‑508‑5p in melanoma inhibits the RAS/RAF/MEK/ERK pathway by direct targeting of KIT"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": ", and studies in pediatric acute lymphoblastic leukemia and lung adenocarcinoma further support its role in mediating chemosensitivity and constraining tumor growth."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": " Finally, in head and neck squamous cell carcinoma, aberrant activation of oncogenic pathways appears to relate – at least in part – to interactions involving miR‑508‑3p."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "17"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in oncogenesis, MIR508 also participates in diverse regulatory networks that influence differentiation, chemoresistance, and other pathophysiological processes. In non‐neoplastic contexts, miR‑508‑5p modulates odontogenic differentiation by regulating GPNMB expression"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "19"}]}, {"type": "t", "text": ", and its interaction with long noncoding RNAs – for example, through sponging by SLCO4A1‑AS1 – further affects colorectal cancer cell proliferation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "20"}]}, {"type": "t", "text": " In nasopharyngeal carcinoma, upregulated circular RNA hsa_circ_0081534 promotes tumor progression by sponging miR‑508‑5p."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "21"}]}, {"type": "t", "text": " Additionally, in middle ear cholesteatoma, miR‑508‑3p directly binds PTEN to modulate the PI3K/Akt pathway"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "22"}]}, {"type": "t", "text": ", and in ossification of the posterior longitudinal ligament its regulation of SATB2 influences osteogenic differentiation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "23"}]}, {"type": "t", "text": " Deregulated miR‑508‑3p also contributes to the pathogenesis of gestational diabetes mellitus via a circ_FOXP1/miR‑508‑3p/SMAD2 axis"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "24"}]}, {"type": "t", "text": ", while circRNA SETDB1–mediated inhibition of miR‑508‑3p alters paclitaxel resistance in ovarian cancer."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "25"}]}, {"type": "t", "text": " Moreover, in periodontitis associated with diabetes, a hsa_circ_0084054/miR‑508‑3p/PTEN regulatory loop has been implicated in disease progression"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "26"}]}, {"type": "t", "text": ", and in preeclampsia, circRNA‐SGK1 modulates the miR‑508‑3p/PUM1 axis"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "27"}]}, {"type": "t", "text": "– further highlighting the broad impact of MIR508 in both malignant and non‐malignant contexts"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "28"}]}, {"type": "t", "text": ", as well as in lung cancer where its regulatory action continues to be elucidated"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "17"}]}, {"type": "t", "text": ", and in head and neck malignancies via similar mechanisms."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "18"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Qingna Zhai, Liang Zhou, Chunjuan Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2012.02.060"}], "href": "https://doi.org/10.1016/j.bbrc.2012.02.060"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22369946"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22369946"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Y Shang, Z Zhang, Z Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2013.297"}], "href": "https://doi.org/10.1038/onc.2013.297"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23893241"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23893241"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Yulong Shang, Bin Feng, Lin Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The miR27b-CCNG1-P53-miR-508-5p axis regulates multidrug resistance of gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.6374"}], "href": "https://doi.org/10.18632/oncotarget.6374"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26623719"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26623719"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Xiangguo Duan, Jing Bai, Jun Wei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-508-5p suppresses metastasis in human gastric cancer by targeting S-phase kinase‑associated protein 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2017.6793"}], "href": "https://doi.org/10.3892/mmr.2017.6793"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28627698"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28627698"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Chuyong Lin, Aibin Liu, Jinrong Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-508 sustains phosphoinositide signalling and promotes aggressive phenotype of oesophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms5620"}], "href": "https://doi.org/10.1038/ncomms5620"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25099196"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25099196"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Gang Bao, Ning Wang, Ruichun Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-508-5p Inhibits the Progression of Glioma by Targeting Glycoprotein Non-metastatic Melanoma B."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurochem Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11064-016-1884-2"}], "href": "https://doi.org/10.1007/s11064-016-1884-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27003587"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27003587"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "S G Wu, Y J Huang, B Bao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-508-5p acts as an anti-oncogene by targeting MESDC1 in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasma (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4149/neo_2017_105"}], "href": "https://doi.org/10.4149/neo_2017_105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27881003"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27881003"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Ting-Ting Yan, Lin-Lin Ren, Chao-Qin Shen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-508 Defines the Stem-like/Mesenchymal Subtype in Colorectal Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-17-2101"}], "href": "https://doi.org/10.1158/0008-5472.CAN-17-2101"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29374066"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29374066"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Lan Hong, Yifeng Wang, Wangsheng Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-508 suppresses epithelial-mesenchymal transition, migration, and invasion of ovarian cancer cells through the MAPK1/ERK signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.27052"}], "href": "https://doi.org/10.1002/jcb.27052"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29781537"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29781537"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "S-J Guo, H-X Zeng, P Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201810_16050"}], "href": "https://doi.org/10.26355/eurrev_201810_16050"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30338806"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30338806"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Linjie Zhao, Wei Wang, Lian Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Integrative network biology analysis identifies miR-508-3p as the determinant for the mesenchymal identity and a strong prognostic biomarker of ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-018-0577-5"}], "href": "https://doi.org/10.1038/s41388-018-0577-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30478449"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30478449"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Siming Liu, Xiaojun Deng, Jiong Zhang "}, {"type": "b", "children": [{"type": "t", "text": "Identification of dysregulated serum miR-508-3p and miR-885-5p as potential diagnostic biomarkers of clear cell renal carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2019.10762"}], "href": "https://doi.org/10.3892/mmr.2019.10762"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31661117"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31661117"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Fei Guo, Kai Zhang, Meiyue Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR‑508‑3p suppresses the development of ovarian carcinoma by targeting CCNA2 and MMP7."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo.2020.5055"}], "href": "https://doi.org/10.3892/ijo.2020.5055"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32377701"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32377701"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Lin Dang, Yan Wang, Cuiping Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A Potential Tumor Suppressor Gene Named miR-508-5p Inhibited the Proliferation and Invasion of Human Melanoma Cells by Targeting KIT."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Technol Cancer Res Treat (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1533033820951801"}], "href": "https://doi.org/10.1177/1533033820951801"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33000689"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33000689"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Atefeh Zamani, Nasrin Fattahi Dolatabadi, Massoud Houshmand, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-324-3p and miR-508-5p expression levels could serve as potential diagnostic and multidrug-resistant biomarkers in childhood acute lymphoblastic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leuk Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.leukres.2021.106643"}], "href": "https://doi.org/10.1016/j.leukres.2021.106643"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34147937"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34147937"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Chaohui Wu, Jiansheng Yang, Xianbin Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-508-5p serves as an anti-oncogene by targeting S100A16 to regulate AKT signaling and epithelial-mesenchymal transition process in lung adenocarcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Sci (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.amjms.2023.02.014"}], "href": "https://doi.org/10.1016/j.amjms.2023.02.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36967030"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36967030"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Xingyou Chen, Chen Feng, Jiliang Zha, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-508-3p regulates the proliferation of human lung cancer cells by targeting G1 to S phase transition 1 (GSPT1) protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Biochim Pol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18388/abp.2020_6660"}], "href": "https://doi.org/10.18388/abp.2020_6660"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38099479"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38099479"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Dan Cui, Zexi Li, Chao Wei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA LINC00491 accelerates head and neck squamous cell carcinoma progression through regulating miR-508-3p/SATB1 axis and activating Wnt signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cytokine (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cyto.2023.156444"}], "href": "https://doi.org/10.1016/j.cyto.2023.156444"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38150791"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38150791"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Fengxi Liu, Xin Wang, Yun Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The suppressive effects of miR-508-5p on the odontogenic differentiation of human dental pulp stem cells by targeting glycoprotein non-metastatic melanomal protein B."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Stem Cell Res Ther (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13287-019-1146-8"}], "href": "https://doi.org/10.1186/s13287-019-1146-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30670091"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30670091"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Zhaozhi Wang, Jianjun Jin "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA SLCO4A1-AS1 promotes colorectal cancer cell proliferation by enhancing autophagy via miR-508-3p/PARD3 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.102081"}], "href": "https://doi.org/10.18632/aging.102081"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31308265"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31308265"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Sujuan Li, Qingshan Wang "}, {"type": "b", "children": [{"type": "t", "text": "Hsa_circ_0081534 increases the proliferation and invasion of nasopharyngeal carcinoma cells through regulating the miR-508-5p/FN1 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.103963"}], "href": "https://doi.org/10.18632/aging.103963"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33082297"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33082297"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Dongliang Liu, Xiulan Ma "}, {"type": "b", "children": [{"type": "t", "text": "MiR-508-3p promotes proliferation and inhibits apoptosis of middle ear cholesteatoma cells by targeting PTEN/PI3K/AKT pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Med Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/ijms.60907"}], "href": "https://doi.org/10.7150/ijms.60907"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34400892"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34400892"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Anlong Jiang, Nanxiang Wang, Xinxing Yan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hsa-circ-0007292 promotes the osteogenic differentiation of posterior longitudinal ligament cells via regulating SATB2 by sponging miR-508-3p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.203381"}], "href": "https://doi.org/10.18632/aging.203381"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34483137"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34483137"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Mingqun Li, Yuqin Huang, Hongli Xi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circ_FOXP1 promotes the growth and survival of high glucose-treated human trophoblast cells through the regulation of miR-508-3p/SMAD family member 2 pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocr J (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1507/endocrj.EJ21-0528"}], "href": "https://doi.org/10.1507/endocrj.EJ21-0528"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35545535"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35545535"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Yu Liu, Yun Liu, Jinyong Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hsa_circ_0002082 up-regulates Centromere Protein F via abolishing miR-508-3p to promote breast cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Lab Anal (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcla.24697"}], "href": "https://doi.org/10.1002/jcla.24697"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36161346"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36161346"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Chunyan Huang, Li Qin, Sailan Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CircSETDB1 contributes to paclitaxel resistance of ovarian cancer cells by sponging miR-508-3p and regulating ABCC1 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Anticancer Drugs (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/CAD.0000000000001465"}], "href": "https://doi.org/10.1097/CAD.0000000000001465"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36729852"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36729852"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Linlin He, Chengcheng Liu, Yiying Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA hsa_circ_0084054 promotes the progression of periodontitis with diabetes via the miR-508-3p/PTEN axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Periodontal Res (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jre.13141"}], "href": "https://doi.org/10.1111/jre.13141"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37212178"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37212178"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "CaiXia Lu, FuMin Zheng, LiXiao Pan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Suppression of circular RNA serum and glucocorticoid-induced kinase 1 elevates antioxidant molecules and angiogenesis in trophoblast cells to attenuate preeclampsia via microRNA-508-3p to target and restrain PUM homolog 1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Obstet Gynaecol Res (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jog.15843"}], "href": "https://doi.org/10.1111/jog.15843"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38081797"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38081797"}]}]}]}
Synonyms MIRN508, HSA-MIR-508
NCBI Gene ID 574513
API
Download Associations
Predicted Functions View MIR508's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR508's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR508's ARCHS4 Predicted Functions.

Functional Associations

MIR508 has 181 functional associations with biological entities spanning 4 categories (molecular profile, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 12 datasets.

Click the + buttons to view associations for MIR508 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR508 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR508 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR508 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR508 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR508 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with MIR508 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing MIR508 from the GeneSigDB Published Gene Signatures dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of MIR508 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR508 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of MIR508 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR508 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR508 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.